- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FDA's Global Strategy Against Counterfeit Medications
Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.
Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.
Operation Pangea VIII, which spanned 115 countries, resulted in more than 2400 websites being taken offline and the seizure of $81 million worth of potential dangerous illegal medicines and medical devices worldwide. The current effort was a part of FDA's Global Strategic Framework for counterfeit and substandard medical products that strives to protect consumers by reducing their exposure to counterfeit and substandard medical products.
Read more about the FDA's effort on FDAVoice.
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
December 18th 2025The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter transformation improved complete response rates and progression-free survival compared with chemoimmunotherapy alone, though overall survival benefits remained unclear.
Read More
